Tag: Statin therapy

Intracerebral hemorrhage (ICH) accounts for nearly 15% of all acute strokes and carries a high fatality rate. A critical, and often complex, medical decision for these patients is determining when to restart statin after hemorrhagic stroke, balancing the risks of recurrent bleeding with the benefits of long-term cardiovascular protection.

For decades, statins have been a cornerstone of cardiovascular disease prevention, but a growing body of research has explored their "pleiotropic" effects beyond cholesterol reduction. This has led to an ongoing debate about whether **can statins improve mood**, with clinical studies yielding conflicting results.